• Consensus Rating: Buy
  • Consensus Price Target: $9.00
  • Forecasted Upside: 1,039.38 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.79
▲ +0.0096 (1.23%)

This chart shows the closing price for IVC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Invacare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IVC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IVC

Analyst Price Target is $9.00
▲ +1,039.38% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Invacare in the last 3 months. The average price target is $9.00, with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 1,039.38% upside from the last price of $0.79.

This chart shows the closing price for IVC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Invacare.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/5/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/3/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/3/2022

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/29/2021OppenheimerLower TargetOutperform$11.00 ➝ $9.00High
9/10/2021Needham & Company LLCLower TargetBuy$17.00 ➝ $8.00Medium
8/19/2021OppenheimerInitiated CoverageOutperform$11.00High
7/14/2020Needham & Company LLCReiterated RatingBuyHigh
6/1/2020Needham & Company LLCReiterated RatingBuy$17.00Medium
5/7/2020Needham & Company LLCReiterated RatingBuy$17.00High
4/14/2020Needham & Company LLCReiterated RatingBuy$17.00High
3/23/2020StephensLower TargetOverweight$17.00 ➝ $11.00High
3/9/2020Needham & Company LLCReiterated RatingBuy$17.00Low
2/10/2020Needham & Company LLCReiterated RatingBuy$17.00Medium
11/6/2019Needham & Company LLCReiterated RatingBuy$15.00High
10/10/2019Needham & Company LLCReiterated RatingBuy$15.00Low
4/9/2019Needham & Company LLCReiterated RatingBuy$15.00Low
2/14/2019Needham & Company LLCReiterated RatingBuy$15.00High
1/24/2019Needham & Company LLCInitiated CoverageBuy ➝ Buy$15.00High
5/9/2018KeyCorpLower TargetOverweight ➝ Overweight$24.00 ➝ $23.00Low
5/2/2018UBS GroupUpgradeSell ➝ NeutralLow
3/15/2018KeyCorpReiterated RatingBuyHigh
2/9/2018KeyCorpBoost TargetOverweight ➝ Overweight$20.00 ➝ $21.00Medium
12/21/2017KeyCorpReiterated RatingBuy$20.00Low
11/10/2017KeyCorpReiterated RatingBuy$18.00N/A
(Data available from 10/3/2017 forward)

News Sentiment Rating

0.45 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/7/2022
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/6/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
5/6/2022
  • 1 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/5/2022
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/5/2022
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/4/2022
  • 1 very positive mentions
  • 16 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/3/2022
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/3/2022

Current Sentiment

  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Invacare logo
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators under the Platinum brand; and Invacare HomeFill oxygen systems. Further, it provides repair, equipment rentals, and external contracting services, as well as distributes heart rate monitors, thermometers, and nebulizers; and portable ramps. The company sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, dealers, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.
Read More

Today's Range

Now: $0.79
Low: $0.79
High: $0.79

50 Day Range

MA: $0.97
Low: $0.78
High: $1.28

52 Week Range

Now: $0.79
Low: $0.76
High: $5.36

Volume

200 shs

Average Volume

643,257 shs

Market Capitalization

$28.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.51

Frequently Asked Questions

What sell-side analysts currently cover shares of Invacare?

The following sell-side analysts have issued stock ratings on Invacare in the last twelve months: Oppenheimer Holdings Inc., and StockNews.com.
View the latest analyst ratings for IVC.

What is the current price target for Invacare?

1 Wall Street analysts have set twelve-month price targets for Invacare in the last year. Their average twelve-month price target is $9.00, suggesting a possible upside of 1,039.4%. Oppenheimer Holdings Inc. has the highest price target set, predicting IVC will reach $9.00 in the next twelve months. Oppenheimer Holdings Inc. has the lowest price target set, forecasting a price of $9.00 for Invacare in the next year.
View the latest price targets for IVC.

What is the current consensus analyst rating for Invacare?

Invacare currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe IVC will outperform the market and that investors should add to their positions of Invacare.
View the latest ratings for IVC.

What other companies compete with Invacare?

Other companies that are similar to Invacare include Predictive Oncology, Nutriband, Sientra, Surgalign and Conformis. Learn More about companies similar to Invacare.

How do I contact Invacare's investor relations team?

Invacare's physical mailing address is ONE INVACARE WAY, ELYRIA OH, 44036. The health services provider's listed phone number is (440) 329-6000 and its investor relations email address is [email protected] The official website for Invacare is www.invacare.com. Learn More about contacing Invacare investor relations.